Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer-Reference-Cited by-同舟云学术

Expression of ERCC1, Bcl-2, Lin28a, and Ki-67 as biomarkers of response to first-line platinum-based chemotherapy in patients with high-grade extrapulmonary neuroendocrine carcinomas or small cell lung cancer

Published:2017-09-11 Issue: Volume:11 Page:
ISSN:1754-6605
Container-title:ecancermedicalscience
language:
Short-container-title:ecancer

Author:

de M Rêgo Juliana Florinda,Salles Scortegagna de Medeiros Raphael,Braghiroli Maria Ignez,Galvão Breno,Evangelista Bezerra Neto João,Ramella Munhoz Rodrigo,Guerra Juliana,Nonogaki Suely,Kimura Lidia,Pfiffer Tulio Eduardo,de Gastro Jr Gilberto,Hoff Paulo Marcelo,Rocha Filho Duilio,Perego Costa Frederico,Riechelmann Rachel P

Publisher

Ecancer Global Foundation

Subject

Cancer Research,Oncology

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Downregulation of MTHFD2 Inhibits Proliferation and Enhances Chemosensitivity in Hepatocellular Carcinoma via PI3K/AKT Pathway;Frontiers in Bioscience-Landmark;2024-01-19

2. ERCC1 and ERCC2 genes expression and their SNPs variants identify a favorable signature for SCLC patients treated with platinum-based chemotherapy;2023-10-10

3. Canadian Consensus Recommendations on the Management of Extensive-Stage Small-Cell Lung Cancer;Current Oncology;2023-06-30

4. Expression of p53 and Rb reveal subtypes of gastric neuroendocrine carcinoma with distinct prognosis;Journal of Neuroendocrinology;2023-03-25

5. Utility of KI-67 as a prognostic biomarker in pulmonary neuroendocrine neoplasms: a systematic review and meta-analysis;BMJ Open;2022-03